SKI Market

A+| A| A-|

Indian Indices

Sensex

74,532.96 325.72
( 0.44%)

Global Indices

Nasdaq

45,612.20 -430.24
(-0.93%)

Dow Jones

6,526.68 -100.81
(-1.52%)

Hang Seng

53,297.18 -1,942.22
(-3.52%)

Nikkei 225

9,927.54 -135.96
(-1.35%)

Forex

USD-INR

93.13 0.41
(0.44%)

EUR-INR

107.17 0.41
(0.39%)

GBP-INR

124.14 0.56
(0.45%)

JPY-INR

0.59 0.00
(0.73%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Lupin Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

500257

INE326A01037

595.6712081

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

LUPIN

19.2

106146

EPS(TTM)

Face Value()

Div & Yield %

120.99

0.52

Back

sru steels ltd

UPL reports consolidated net profit of Rs 553.00 crore in the September 2025 quarter

Nov 06,2025

Net profit of UPL reported to Rs 553.00 crore in the quarter ended September 2025 as against net loss of Rs 443.00 crore during the previous quarter ended September 2024. Sales rose 8.38% to Rs 12019.00 crore in the quarter ended September 2025 as against Rs 11090.00 crore during the previous quarter ended September 2024.

Particulars	Quarter Ended
	Sep. 2025	Sep. 2024	% Var.
Sales	12019.00	11090.00	8
OPM %	36.84	30.84	-
PBDT	3894.00	2461.00	58
PBT	3123.00	1764.00	77
NP	553.00	-443.00	LP

74,532.96 325.72 ( 0.44%)

45,612.20 -430.24 (-0.93%)

6,526.68 -100.81 (-1.52%)

53,297.18 -1,942.22 (-3.52%)

9,927.54 -135.96 (-1.35%)

93.13 0.41 (0.44%)

107.17 0.41 (0.39%)

124.14 0.56 (0.45%)

0.59 0.00 (0.73%)